Reelin
Showing 1 - 9 of 9
Treatment-resistant Depression Trial in Hangzhou (active iTBS, sham rTMS)
Recruiting
- Treatment-resistant Depression
- active iTBS
- sham rTMS
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Jan 12, 2023
Treatment Resistant Depression, Visual Perceptual Weakness Trial in Hangzhou (Repetitive Transcranial Magnetic Stimulation)
Not yet recruiting
- Treatment Resistant Depression
- Visual Perceptual Weakness
- Repetitive Transcranial Magnetic Stimulation
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Sep 12, 2023
Treatment-Resistant Depression Trial in Hangzhou (non-invasive transcranial deep brain stimulation, Sham stimulation, Motor
Recruiting
- Treatment-Resistant Depression
- non-invasive transcranial deep brain stimulation
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Mar 8, 2023
Obesity Trial in Geneva (Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml or Placebo)
Completed
- Obesity
- Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml or Placebo
-
Geneva, SwitzerlandUniversity Hospitals of Geneva
Apr 29, 2021
Depressive Disorder Trial in Zhejiang (Antidepressant, Psychotherapy IPT, The combination of antidepressant and IPT)
Recruiting
- Depressive Disorder
- Antidepressant
- +2 more
-
Zhejiang, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang University
Jun 23, 2023
Ultra High Risk for Psychosis Trial in Worldwide (Omega-3 fatty acids, Placebo)
Active, not recruiting
- Ultra High Risk for Psychosis
- Omega-3 fatty acids
- Placebo
-
Vienna, Austria
- +13 more
Feb 8, 2021
Gene Promoter DNA Methylations and Their Relationships With
Unknown status
- Schizophrenia
-
Taipei, Taiwan
- +1 more
Jun 27, 2012
GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy
Unknown status
- Bipolar Disorder
-
Sao Paulo, BrazilInstitute of Psychiatry HCFMUSP
Aug 15, 2011